Title of Study. Sickle Cell Disease and Hydroxyurea Use
Funding Status. Pending (NIH R21 submitted February 2017)
PI: Julie Panepinto
Project Focus/Research Question. At site level, look at which patients are on hydroxyurea and who is not but should be; difference in use between tertiary care centers vs. non-tertiary care centers.
Study Design. Observational